Medco Research
Executive Summary
Joint clinical research program with Bristol-Myers Squibb Diagnostics will study the combination of Medco's Adenoscan, a drug used in conjunction with cardiac imaging, with Squibb's cardiac imaging agent Cardio Tec. Medco says the combo may be superior to the use of exercise stress in conjunction with thallium-201, providing high-quality images in less than one hour. NDAs for both products are pending at FDA. Medco, which has hired investment banker Oppenheimer & Co. to explore the sale of the company ("The Pink Sheet" April 16, T&G-9), says the arrangement does not represent a licensing of any of the firm's rights to Adenoscan, held by Lyphomed.